$19.24
-2.02 (-9.50%)
Open$20.59
Previous Close$21.26
Day High$20.91
Day Low$19.19
52W High$25.15
52W Low$17.87
Volume—
Avg Volume679.2K
Market Cap1.41B
P/E Ratio3.93
EPS$4.05
SectorPharmaceuticals
Analyst Ratings
Strong Buy
11 analysts
Price Target
+103.5% upside
Current
$19.24
$19.24
Target
$39.16
$39.16
$23.99
$39.16 avg
$41.33
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 354.52M | 329.85M | 296.49M |
| Net Income | 233.71M | 195.70M | 100.45M |
| Profit Margin | 65.9% | 62.6% | 33.9% |
| EBITDA | 153.16M | 135.37M | 161.71M |
| Free Cash Flow | — | — | 84.32M |
| Rev Growth | +7.5% | +7.5% | +12.4% |
| Debt/Equity | 0.22 | 0.22 | 0.49 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |